Department of Pediatrics, Center for Endocrinology, Diabetes, and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Department of Pediatrics, The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Front Endocrinol (Lausanne). 2022 Feb 25;13:841838. doi: 10.3389/fendo.2022.841838. eCollection 2022.
Randomized controlled trials of time restricted eating (TRE) in adults have demonstrated improvements in glucose variability as captured by continuous glucose monitors (CGM). However, little is known about the feasibility of CGM use in TRE interventions in adolescents, or the expected changes in glycemic profiles in response to changes in meal-timing. As part of a pilot trial of TRE in adolescents with obesity, this study aimed to 1) assess the feasibility of CGM use, 2) describe baseline glycemic profiles in adolescents with obesity, without diabetes, and 3) compare the difference between glycemic profiles in groups practicing TRE versus control.
This study leverages data from a 12-week pilot trial (ClinicalTrials.gov Identifier: NCT03954223) of late TRE in adolescents with obesity compared to a prolonged eating window. Feasibility of CGM use was assessed by monitoring 1) the percent wear time of the CGM and 2) responses to satisfaction questionnaires. A computation of summary measures of all glycemic data prior to randomization was done using EasyGV and R. Repeat measures analysis was conducted to assess the change in glycemic variability over time between groups. Review of CGM tracings during periods of 24-hour dietary recall was utilized to describe glycemic excursions.
Fifty participants were enrolled in the study and 43 had CGM and dietary recall data available (16.4 + 1.3 years, 64% female, 64% Hispanic, 74% public insurance). There was high adherence to daily CGM wear (96.4%) without negative impacts on daily functioning. There was no significant change in the glycemic variability as measured by standard deviation, mean amplitude glycemic excursion, and glucose area under the curve over the study period between groups.
CGM use appears to be a feasible and acceptable tool to monitor glycemic profiles in adolescents with obesity and may be a helpful strategy to confirm TRE dosage by capturing glycemic excursions compared to self-reported meal timing. There was no effect of TRE on glucose profiles in this study. Further research is needed to investigate how TRE impacts glycemic variability in this age group and to explore if timing of eating window effects these findings.
限时进食(TRE)的随机对照试验已证明,通过连续血糖监测仪(CGM)可改善葡萄糖变异性。然而,对于 TRE 干预措施中 CGM 在青少年中的应用可行性,以及对进餐时间变化的血糖谱变化的预期变化知之甚少。作为肥胖青少年 TRE 试验的一部分,本研究旨在:1)评估 CGM 的使用可行性;2)描述无糖尿病肥胖青少年的基线血糖谱;3)比较接受 TRE 与对照组的青少年的血糖谱差异。
本研究利用一项为期 12 周的肥胖青少年 TRE 试验的初步数据(临床试验标识符:NCT03954223),与延长进食窗口进行比较。通过监测 1)CGM 的佩戴时间百分比和 2)对满意度问卷的反应来评估 CGM 使用的可行性。在随机分组之前,使用 EasyGV 和 R 计算所有血糖数据的综合指标。进行重复测量分析以评估组间随时间变化的血糖变异性变化。在 24 小时膳食回忆期间查看 CGM 轨迹,以描述血糖波动。
该研究共纳入 50 名参与者,其中 43 名参与者有 CGM 和膳食回忆数据(16.4 ± 1.3 岁,64%为女性,64%为西班牙裔,74%为公共保险)。每日 CGM 佩戴率高(96.4%),且对日常功能无不良影响。在研究期间,两组之间的血糖变异性测量值(标准差、平均幅度血糖波动和血糖曲线下面积)没有显著变化。
CGM 的使用似乎是监测肥胖青少年血糖谱的一种可行且可接受的工具,并且与自我报告的进餐时间相比,通过捕捉血糖波动,可能是确认 TRE 剂量的有用策略。在这项研究中,TRE 对葡萄糖谱没有影响。需要进一步研究 TRE 对该年龄段血糖变异性的影响,并探讨进餐时间窗口是否会影响这些发现。